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Unique properties of a subset of human pluripotent
stem cells with high capacity for self-renewal
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Archetypal human pluripotent stem cells (hPSC) are widely considered to be equivalent in
developmental status to mouse epiblast stem cells, which correspond to pluripotent cells at a
late post-implantation stage of embryogenesis. Heterogeneity within hPSC cultures compli-
cates this interspecies comparison. Here we show that a subpopulation of archetypal hPSC
enriched for high self-renewal capacity (ESR) has distinct properties relative to the bulk of the
population, including a cell cycle with a very low G1 fraction and a metabolomic profile that
reflects a combination of oxidative phosphorylation and glycolysis. ESR cells are pluripotent
and capable of differentiation into primordial germ cell-like cells. Global DNA methylation
levels in the ESR subpopulation are lower than those in mouse epiblast stem cells. Chromatin
accessibility analysis revealed a unique set of open chromatin sites in ESR cells. RNA-seq at
the subpopulation and single cell levels shows that, unlike mouse epiblast stem cells, the ESR
subset of hPSC displays no lineage priming, and that it can be clearly distinguished from
gastrulating and extraembryonic cell populations in the primate embryo. ESR hPSC corre-
spond to an earlier stage of post-implantation development than mouse epiblast stem cells.
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The successful application of human pluripotent stem cells(hPSC) in research and cell therapy relies on the ability tomaintain, expand, and differentiate these cells in vitro in a
tightly controlled and efficient fashion. Our understanding of the
regulation of pluripotent stem cell self-renewal and lineage spe-
cification is in turn built largely on embryological paradigms,
with developmental roadmaps providing critical knowledge of the
key transitional stages, and pinpointing the extrinsic and internal
molecular pathways drive cell fate decisions. In the mouse, we
now have a fairly clear understanding of the states of pluripotency
that span the developmental stages between the blastocyst and the
late gastrula in vivo1. The characterization of mouse naive
embryonic stem cells (ESC)2 and epiblast stem cells (EpiSC)3,4 as
in vitro equivalents of the preimplantation epiblast and the
anterior primitive streak, respectively5, has shed considerable
light on the properties of the cultured cells. Recently, a stage
between these two pluripotent states called formative plur-
ipotency, corresponding to the early post-implantation epiblast,
has been described6. Defined by specific molecular and biological
features, including an absence of lineage priming and a rapid
response to induction of lineage specification (including the
germline lineage), formative mouse pluripotent stem cells have
yet to be successfully serially propagated in vitro.
The derivation of mouse EpiSC, their characterization as epi-
thelial cells dependent upon activin and FGF2 for maintenance in
the pluripotent state3,4, and their co-expression of lineage-specific
and pluripotency genes4,5,7–10, led many researchers to the con-
clusion that hPSC derived and maintained under conventional
culture conditions (archetypal hPSC), which share these features,
equate to the primed state of mouse pluripotency. This in turn led
to a search for conditions that would support long-term main-
tenance of hPSC in a naive state11,12. Several culture systems have
been described that support a cell with molecular features quite
similar to the human preimplantation epiblast13,14. Extended
propagation of diploid hPSC in these systems remains challen-
ging, however.
Population heterogeneity complicates the interpretation of
stem cell phenotype. To dissect heterogeneous populations in
archetypal hPSC cultures, we used monoclonal antibodies to cell
surface antigens to define subsets of stem cells that exist in a
hierarchical continuum of cell states. When we subjected these
cells to transcriptional profiling, we observed co-expression of
pluripotency genes with lineage specific transcription factors,
particularly in subpopulations of cells with lower levels of stem
cell surface marker and pluripotency gene expression15. Impor-
tantly though, we also found that cells which expressed plur-
ipotency markers at high levels were less likely to display lineage
priming.
Subsequently by analyzing cells grown under defined condi-
tions, and using a more refined sorting strategy to isolate the
subpopulation enriched for high self-renewal (ESR) followed by
medium throughput single-cell RT-QPCR, we were able to show
that the cells at the top of the hierarchy expressed very uniform
and high levels of pluripotency markers, and showed no lineage
priming16.
As cells traverse through stages of pluripotency in vitro and
in vivo, they undergo changes in cell cycle regulation and meta-
bolic activity, they restructure their epigenome, and their gene
expression profile changes. The ability to sort highly purified
populations of hPSC with high self-renewal capacity, and to
analyse transcription in these subpopulations at the genomic level
using RNA-Seq for subpopulation and single cell analysis, cou-
pled with the availability of new single-cell gene expression data
from preimplantation and post-implantation primate embryos,
prompted us to re-examine the properties of the ESR sub-
population of archetypal hPSC, and to reconsider its
developmental status. The results show that the ESR subpopula-
tion resembles the primate early post-implantation epiblast,
similar to the mouse formative state of pluripotency.
Results
Self-renewal of subsets of hPSC. We have previously used flow
cytometry to isolate cell subpopulations, followed by assay of
colony forming ability as an indicator of self-renewal15,17. hPSC
survival after dissociation to single cells and flow cytometry is
poor. We therefore developed a simple methodology that would
allow comparison of self-renewal of defined cell populations at
reasonable levels of initial survival after flow cytometry, through
sorting small aggregates of cells, to maintain cell–cell contacts and
enhance post-sort survival18.
Fluorescence activated cell sorting using antibodies GCTM-2
and TG30 (recognizing CD9) enabled us to recover small cell
aggregates (chiefly doublets; singlets, 17%; doublets, 61%; triplets,
16%; quadruplets, 6%) (Fig. 1a). We seeded wells with equal cell
numbers as aggregates or singlets. Although both aggregates and
single cells attached to the plate after sorting, a much larger
fraction of the aggregates had begun to spread 1 h after plating,
indicative of high viability; the difference was more evident after
24 h (Fig. 1b). Initial attachment, spreading and survival of the
GCTM-2highCD9high subpopulation was similar to the GCTM-
2midCD9mid subpopulation. Flow cytometry re-analysis of both
subpopulations 72 h later showed that they had largely retained
their cell surface phenotypes though as shown previously19, the
GCTM-2highCD9high population had begun to reconstruct the
entire cell state continuum (Fig. 1c). By 4 days, cells plated as
aggregates displayed a higher colony forming efficiency than
single cells, and the GCTM-2highCD9high subpopulation had
formed a much larger number of microcolonies (Fig. 1d–e).
Colonies formed from GCTM-2highCD9high aggregates were
larger and showed a higher proportion of cells bearing stem cell
markers compared with colonies formed by GCTM-2midCD9mid
cells (Fig. 1f). Time-lapse video microscopy confirmed that the
initial cell numbers attaching to the dish were similar for the two
subpopulations. However, subsequent monitoring showed that
while both subpopulations were migratory and underwent cell
division, the GCTM-2highCD9high subpopulation persisted to
form colonies of 4–32 cells several days later, whereas the GCTM-
2midCD9mid colonies suffered abortive expansion and, in many
cases, extinction (Supplementary Movies 1 and 2).
Differentiation potential of hPSC subpopulations. In the
mouse, the ability to differentiate efficiently into germ cells in vitro
is limited to epiblast like cells at the stage of formative
pluripotency20,21. Naive pluripotent stem cells or epiblast stem
cells both lack this capacity21. Using the two-step protocol to
generate first a mesoderm-like intermediate and subsequently
convert these cells to PGC-like cells22, we measured the degree of
differentiation of the GCTM-2highCD9highEPCAMhigh and
GCTM-2midCD9mid populations using flow cytometry to quanti-
tate EPCAM/ITGA6 double high cells which represent PGC-like
cells (Fig. 2a). GCTM-2highCD9highEPCAMhigh cells showed
higher expression of EPCAM and ITGA6 at the onset, as expected.
After 2 days of differentiation into mesoderm-like cells, both
groups showed loss of EPCAM expression but at Day 4 after PGC-
like cell induction, an EPCAM/ITGA6 double positive fraction
was observed in both groups. Cultures that did not receive growth
factors to induce germ cell formation contained no EPCAM/
ITG6A double high population. The GCTM-2highCD9high
EPCAMhigh population had largely disappeared by the end of the
time course, as noted by Sasaki et al.22. The identity of the PGC-
like cells was confirmed by staining with antibodies to PRDM1
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and NANOS3 (Fig. 2b). More PGC-like cells were consistently
obtained from GCTM-2highCD9highEPCAMhigh compared with
GCTM-2midCD9mid subpopulations in both cell lines, though
there was a high degree of inter-assay variability (Fig. 2c). We and
others have shown previously that the ESR fraction of hPSC is
pluripotent (Figs. 4 and 5, refs. 17,19). In this study, directed dif-
ferentiation in adherent culture, carried out on cell lines WA09
and WA01, confirmed that both the GCTM-2highCD9high
subpopulation and the remaining cell population were pluripotent,
as measured by expression of markers characteristic of progenitors
of all three embryonic germ layers (Fig. 2d).
ESR cells have a cell cycle with a low G1 fraction. Initial analyses
of the mouse ESC cell cycle indicated that naive mouse ESC, and
cells of the epiblast, show a shortened cell cycle with a minimal
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G1 component23. While more recent work shows that the cell
cycle state of naive mouse stem cells is dependent upon culture
conditions24, it remains clear that lineage commitment is coupled
to cell cycle regulation in mouse and human PSC, and that the G1
phase represents a decision point for undergoing lineage speci-
fication25–27.
Here we re-assessed our previous finding that a subset of cells
expressing high levels of the stem cell antigen GCTM-2 had a
reduced G1 fraction compared with the remainder of the
population28. Using a more refined sorting procedure and EdU
incorporation to identify S-phase cells. we determined the cell
cycle phase distribution of GCTM-2highCD9highEPCAMhigh,
GCTM-2highCD9high, and GCTM-2lowCD9low subpopulations,
compared with unsorted cells (the general population). As shown
in Fig. 3, very few of the GCTM-2highCD9highEPCAMhigh or
GCTM-2highCD9high cells were in G0/G1 phase, with most of this
subpopulation in S or G2/M. By contrast, GCTM-2lowCD9low
cells were predominantly in G0/G1 (~70%). The cell cycle phase
distribution of the unsorted general population was consistent
with these findings. Results using a different WA09 subline with a
FUCCI reporter29 confirmed these conclusions (Supplementary
Fig. 1).
Active mitochondria and bivalent metabolism in ESR cells.
Metabolic activity is modulated throughout early mammalian
development. The preimplantation relies on a combination of
aerobic glycolysis and oxidative phosphorylation, and this meta-
bolic pattern is maintained during post-implantation develop-
ment up to E7.5 in the mouse30. Like the epiblast, naive state
mouse ESC show this bivalent metabolism, while primed epiblast
stem cells rely primarily on glycolysis31. Similar transitions from
bivalent metabolism to glycolysis have been reported during
conversion of naive to primed hPSC32,33.
To determine if the energy metabolism status of hPSC is
dependent on their position in the pluripotency hierarchy, we
first assessed the mitochondrial membrane potential of defined
subsets of hPSC by measuring the uptake of the mitochondrial
dye tetramethylrhodamine methyl ester (TMRM), or the
combined uptake and the ratio of red/green fluorescence of the
dye JC-1. Live cell staining of WA09 cells showed that staining
with TMRM was strongest at the edge of the colonies, where cells
expressing the highest levels of the stem cell marker CD9 are
found (Fig. 4a). To quantitate mitochondrial activity across the
cell populations, WA09 cells were incubated with TMRM or JC-1,
labeled with stem cell surface makers GCTM-2, TG30 (anti-CD9),
and anti-EPCAM, and the GCTM-2highCD9highEPCAMhigh and
GCTM-2lowCD9low fractions were identified by flow cytometry.
The GCTM-2highCD9highEPCAMhigh subpopulation stained
more intensely with TMRM, and showed higher ratio of red to
green fluorescence following incubation with JC-1 compared with
the general (remaining) population, or the GCTM-2lowCD9low
subpopulation (Fig. 4b–c), indicating increased mitochondrial
activity in the GCTM-2highCD9highEPCAMhigh subpopulation.
Analysis of mitochondrial oxidative phosphorylation in live
cells using the Agilent Seahorse XF apparatus confirmed that the
basal oxygen consumption rate (OCR) was higher in the GCTM-
2highCD9highEPCAMhigh subpopulation compared with the
remaining GEN population (Fig. 5a). These cells also exhibited
higher spare mitochondrial capacity, as indicated by maximum
OCR achieved after addition of proton uncoupling agent FCCP
(Fig. 5a). Comprehensive analysis of intracellular metabolite
levels in the GCTM-2highCD9highEPCAMhigh cells and unfrac-
tionated population using liquid chromatography and gas
chromatography–mass spectrometry (LC–MS, GC–MS) provided
further evidence that the GCTM-2highCD9highEPCAMhigh cells
exist in a distinct metabolic state. Principal Component Analysis
(PCA, Supplementary Fig. 2a, b) and hierarchical cluster analysis
(Fig. 5b, LC–MS; Supplementary Fig. 2c, GC–MS) clearly
separated the purified cell population from the GEN population.
Consistent with the live cell staining and OCR analysis, the
GCTM-2highCD9highEPCAMhigh contained elevated levels of
TCA cycle metabolites (Fig. 5c) and was depleted in many
amino acids and metabolites in the urea cycle (Supplementary
Tables 1–2), compared with the general population. Pathway
analysis further confirmed the distinct metabolic profile of the
GCTM-2highCD9highEPCAMhigh subpopulation (Supplementary
Fig. 2d, e).
To gain further insights into the metabolic wiring of this
subpopulation of cells, GCTM-2highCD9highEPCAMhigh fractio-
nated cells and the GEN population of hPSC were cultivated in
the presence of 13C glucose for 2 h and level of 13C-enrichment in
different intermediates of central carbon metabolism monitored
by GC–MS. High levels of 13C-enrichment were observed in all
intermediates in glycolysis and the pentose phosphate pathway
confirming that both cell populations exhibit high rates of aerobic
glycolysis (Fig. 5d). Interestingly, 13C-enrichment in serine and
glycine, which are synthesized from the glycolytic intermediate 3-
phosphoglycerate, were higher in the GCTM-2highCD9highEP-
CAMhigh cells, indicating that these cells may have higher rates of
amino acid and protein synthesis. Consistent with GCTM-
2highCD9highEPCAMhigh cells having elevated rates of mitochon-
drial metabolism, 13C-enrichment in citrate and isocitrate were
substantially upregulated in this subpopulation (Fig. 5d). How-
ever, 13C-enrichment in later intermediates in the oxidative cycle
(succinate, fumarate, and malate) were not significantly changed
between the two cell populations indicating that early inter-
mediates in the TCA cycle may be diverted into anabolic
pathways (catapleurosis). Increased catapleurosis in the GCTM-
2highCD9highEPCAMhigh cells was supported by the elevated
levels of 13C-labeling in glutamate, which is synthesized from the
TCA cycle intermediate, α-ketoglutarate, as well as high levels of
13C-enrichment in long chain unsaturated fatty acids (i.e., oleic
acid) and cholesterol, indicating high rates of membrane
biogenesis or turnover. Overall, these data provide compelling
evidence that the GCTM-2highCD9highEPCAMhigh cells are
metabolically more active than the GEN hPSC population,
Fig. 1 Assay of self-renewal of subpopulations of hPSC under conditions that maintain cell–cell contacts. a Isolation of aggregates of subsets of hPSC by
flow cytometry. Left panel, side and forward scatter; middle panel, separation of single cells using GCTM-2 and anti-CD9; right panel, separation of cell
aggregates using GCTM-2 and anti-CD9. b Phase contrast image of aggregates and single cells 1 and 24 h after plating. At 1 h, both populations of
aggregates (GCTM-2highCD9high, HIGH and GCTM-2midCD9mid, MID) have attached and spread onto the substrate. Scale bar= 100micron. c Flow
cytometry analysis of cell surface antigen expression in aggregate cultures prepared as in a 72 h after plating. dMicrocolony formation after 4 days by single
cells (200, 1000, or 2000) or aggregates (100, 500, or 1000) of GCTM-2highCD9high (HS, HA) and GCTM-2midCD9mid (MS, MA) subpopulations.
e Numbers of microcolonies formed at 4 days by GCTM-2highCD9high or GCTM-2midCD9mid single cells or aggregates (AGG). Values represent the mean ±
standard deviation from eight wells from one experiment; see Supplementary Table 5 for biological replicates of this assay. f Immunostaining with stem cell
surface marker antibody GCTM-2 of colonies formed by aggregates of GCTM-2midCD9mid and GCTM-2highCD9high subpopulations. Scale bar= 100micron.
Results in b, d, and f display representative outcomes from three experiments.
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exhibiting higher rates of oxidative phosphorylation and anabolic
amino acid and lipid synthesis.
DNA methylation in hPSC cultured under defined conditions.
Levels of DNA methylation in the mouse and human epiblast are
low, but increase substantially in the mouse following embryo
implantation and activation of the de novo methyltransferases
Dnmt3a and Dnmt3b34,35. Reduced representation bisulfite
sequencing to assess levels of DNA methylation showed no major
differences between the relatively low mean levels of overall DNA
methylation or levels of DNA methylation over CpG islands
between the GCTM-2highCD9highEPCAMhigh subpopulation and
the general population (Fig. 6a, b). DNA methylation distribu-
tions were bimodal (Fig. 6c, d), and there was little evidence of
differential methylation at CpG islands across any particular loci
in the GCTM-2highCD9highEPCAMhigh subpopulation (Fig. 6e).
The extent of DNA methylation at CpG islands in various repeat
elements was high and did not vary between the unsorted and
GCTM-2highCD9highEPCAMhigh fraction (Fig. 6f). De novo DNA
methyltransferases DNMT3A and DNMT3B were both expressed
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along with TET1 across the cell populations studied (below and
Supplementary Fig. 3a–j), similar to the early post-implantation
epiblast in the mouse36, and suggestive of a highly dynamic state
of DNA methylation in these cells.
Differential chromatin accessibility in hPSC subpopulations.
We next identified critical differences in the chromatin landscape
between GCTM-2highCD9highEPCAMhigh and GCTM-2mid-
CD9mid populations using the assay for transposase accessible
chromatin37. In total, we identified 118,442 regions as accessible
across both populations. Of these, 3144 were more accessible in
the GCTM-2highCD9highEPCAMhigh cells, while 4730 were more
accessible in the GCTM-2midCD9mid population (Fig. 7a, FDR <
0.01; quality assessment data Supplementary Fig. 4, Supplemen-
tary Data 1). Generally, peaks with increased accessibility in the
high population were distant from transcription start sites (TSS),
more often found in intergenic and introns typical of enhancers,
whereas peaks with increased accessibility in the middle popu-
lations were closer to TSS (Fig. 7b) identified as promoters
(Supplementary Fig. 5a). To annotate open chromatin sites in
each population we compared their location to the entire set of
transcription factor (TF) binding sites across a diverse range of
human cell types identified by the ENCODE project38 using a
locus overlap enrichment analysis39 (Supplementary Data 2).
Genomic locations more accessible in the GCTM-2high-
CD9highEPCAMhigh population were highly enriched for TF
binding sites identified in hPSC compared with the GCTM-
2midCD9mid population (Fig. 7c). Furthermore, the most enriched
TFs binding at the GCTM-2highCD9highEPCAMhigh population
sites included known pluripotency factors NANOG, POU5F1
(OCT4), and TCF12 and BCL11A (Fig. 7d, upper panel), the
latter two TF having been previously identified as highly
expressed in the GCTM-2highCD9highEPCAMhigh population16.
While these same factors were still identified as enriched in the
regions in the GCTM-2midCD9mid populations, other general
chromatin factors showed the highest overlap (Fig. 7d, lower
panel). Finally, we compared regions of increased accessibility in
both populations to the tissue and cell-type specific DNAse
hypersensitivity clusters identified in human samples40. Again,
this analysis identified that the regions with greatest enrichment
in the GCTM-2highCD9highEPCAMhigh population were anno-
tated as being unique to stem cells (Supplementary Fig. 5b, c). In
summary, these data indicate that the GCTM-2high-
CD9highEPCAMhigh population has greater open chromatin at
putative enhancers bound by canonical pluripotent factors at sites
unique to stem cells, whereas the low population has greater DNA
accessibility at promoters bound by general chromatin and
transcription factors. Together these data support the hypothesis
that the chromatin of cells in the GCTM-2high-
CD9highEPCAMhigh population exists in a distinct state com-
pared with the low population.
Comparison of ESR cell transcriptome with primate epiblast.
RNA-seq analysis comparing gene expression in the GCTM-
2highCD9highEPCAMhigh subpopulation to the general (total
unfractionated) population (Supplementary Data 3) identified
515 genes differentially expressed between the GCTM-2high-
CD9highEPCAMhigh subset and the total population (132 upre-
gulated in the GCTM-2highCD9highEPCAMhigh cells and 383
downregulated relative to the unfractionated cells, at >1.5-fold
change in expression level with an adjusted p value <0.05; Fig. 8a).
Genes upregulated in the GCTM-2highCD9highEPCAMhigh
fraction included NODAL and its antagonists LEFTY1 and
LEFTY2, in agreement with our previous study16. POU3F1, a
marker of the naive to formative transition in the mouse, was also
upregulated. Notably, a number of small nuclear and small
nucleolar RNAs were expressed at high levels in the GCTM-
2highCD9highEPCAMhigh population. Negative regulators of
MAPK signaling, including DUSP5 (inactivator of ERK1), DUSP6
(inactivator of ERK2), and SPRY2, were upregulated in the self-
renewing fraction, as was DACT1 (an antagonist of canonical
WNT signaling). Negative regulators of MAPK signaling
including Dusp4 and Spry were recently shown to be upregulated
at an early stage during dissolution of the mouse naive state41.
Amongst the genes expressed at lower levels in the GCTM-
2highCD9highEPCAMhigh cellular subset relative to the unfractio-
nated population were members of the WNT signaling pathway,
including WNT4, FRZB, FZD3, FZD5, and FZD8. Of the top 100
genes upregulated in the general population, 47 genes (all
upregulated at twofold change or higher) were previously
reported to be expressed at peak levels at the onset of neural
differentiation in the CORTECON study of Temple and
colleagues42 (global analysis, Supplementary Fig. 6). Examination
of previously published microarray data43 for a subset of these
neural induction genes confirmed a pattern of continuous
upregulation in cell subsets with decreasing levels of pluripotency
associated cell surface markers in multiple cell lines (Supplemen-
tary Fig. 7, data visualized in the Stemformatics platform https://
www.stemformatics.org). BMP2, BMP4, and FST were also
upregulated in the general population, consistent with our
previous results16.
Some genes characteristic of the primate preimplantation
epiblast and naive hPSC were expressed in the GCTM-2high-
CD9highEPCAMhigh fraction (PRDM14, TFCP2L1, ZFP42,
DPPA2, and TFAP2C), but others were not (ARGFX, KLF17,
TBX3, NLRP7). Genes expressed in primitive endoderm (SOX17,
GATA4, GATA6, FOXA2, and APOA2) were not found in either
the GCTM-2highCD9highEPCAMhigh or the general population,
nor were genes activated during early gastrulation (T, MIXL,
GSC, EOMES, FOXA2, LHX1).
scRNA-seq on hPSC fractionated into four separate subpopu-
lations enabled us to compare gene expression in the fractionated
subpopulations with the single-cell data of Nakamura et al.44 for
Macaca fascicularis pre- and post-implantation embryos (quality
Fig. 2 Differentiation potential of GCTM-2highCD9highEPCAMhigh and GCTM-2midCD9mid subpopulations. a Flow cytometry assay showing
differentiation of GCTM-2highCD9highEPCAMhigh subpopulation into PGC-like cells. Panels show flow cytometry analysis for expression of EPCAM and
ITGA6 in starting population (Day 0), post induction of incipient mesoderm-like cell with ACV and CHIR99021 (Day2), and PGC induction (addition of
BMP4, LIF, KITLG, and EGF) versus controls without these factors (Days 4 + and − factors). b Staining of aggregates of PGC-like cells for PRDM1 or
NANOS3 on Day 4. Aggregates incubated with cytokines showed strong nuclear staining; those incubated in the absence of factors did not. DNA staining
to right of each image. Scale bar PRDM1 panels 50 μM; NANOS3 and 2nd antibody only, 100 μM. Staining with secondary antibody alone in bottom panel.
c Table showing percentage yield of EPCAM+ITG6A+ cells on Day 4 in two cell lines for GCTM-2highCD9highEPCAMhigh and GCTM-2midCD9mid
subpopulations. d Directed differentiation of the GCTM-2highCD9high fraction and the remaining population of WA09 and WA01 cells in adherent culture.
Panels show staining for PAX6, T, and SOX17 after induction of differentiation for 5 days. Numbers on each panel represent the proportion of cells positive
for the indicated marker ± 95% confidence interval. Scale bar= 100 μM, same magnification in all panels. Results in b and d display representative
outcomes from two experiments on two cell lines.
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assessment, Supplementary Figs. 8–9). We analyzed 300 cells, and
we detected expression of 8403 genes. All cells uniformly
expressed the general pluripotency associated transcription
factors POU5F1, SOX2, and NANOG (Supplementary Fig. 10a–
d)). ZFP42, a marker of the naive state in mouse, was expressed
throughout the population, but another naive state marker,
TFCPL1 was expressed primarily in the GCTM-2highCD9highEP-
CAMhigh and GCTM-2highCD9high subsets; POU3F1, character-
istic of post-implantation epiblast, was expressed throughout
(Supplementary Fig. 10e–g). PCA of the human cell
subpopulations alone indicated that they could be clearly
separated along a continuum of cell states (Fig. 8b). Ontology
analysis of differential gene expression highlighted a number of
pathways involving ribonucleoprotein complexes, ribosomes, and
metabolic processes, in concurrence with the expression of small
nuclear and nucleolar RNAs noted above in the subpopulation
analysis (Supplementary Table 3), and a number of pathways
related to oxidative metabolism, including metabolic processes,
mitochondrion, mitochondrion organization, generation of
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precursor metabolites and energy, mitochondrial inner mem-
brane, and hydrogen ion transmembrane transporter activity.
The GCTM-2highCD9highEPCAMhigh subset and general
populations both expressed markers of the post-implantation
mouse epiblast, including POU3F1, OTX2, DNMT3A, DNMT3B,
SOX4, SOX11, LIN28A, and ZNF281 (Supplementary Data 3). In
a PCA of the human single-cell data and the cynomolgus data of
Nakamura et al.44 (Fig. 8c), the first principal component resolved
the two experiments with cynomolgus and human cells. The
second principal component resolved the inner cell mass and pre-
and post-implantation epiblast, along with extraembryonic cells.
In this dimension, the human cells aligned with preimplantation
epiblast stage cells. In the third principal component, which
separated post-implantation stages of cynomolgus development,
human cells aligned with the post-implantation epiblast, with
cells in the GCTM-2highCD9highEPCAMhigh fraction between
early and late post-implantation stages. The human cells were
clearly distinguished from inner cell mass and preimplantation
epiblast stages, from gastrulating cells, and from extraembryonic
tissues. PCA of the cynomolgus cells alone revealed that it was
difficult to separate early from late post-implantation epiblast
(Supplementary Fig. 11).
The cells used in this study were WA09 cells grown on mTeSR
in feeder-free, serum-free conditions. To assess the generality of
these findings, we compare these results with two previous
microarray analyses: an independent study that examined
similarly defined subpopulations of cell lines MEL1 and WA09
grown in proprietary serum replacement with mouse embryo
fibroblast feeders or mTeSR1 (WA09)43, and our previous study
using cell line ES02 grown in serum-supplemented medium in the
presence of mouse fibroblast feeder cells17. We identified a panel
of stage-specific genes (Supplementary Table 4) on the basis of
their differential expression in the data of Nakamura et al.44 and a
recent scRNA-seq study of the human preimplantation embryo45
(Fig. 9). Genes specific to the inner cell mass, or mainly expressed
in the inner cell mass and preimplantation epiblast, were very
weakly expressed in the GCTM-2highCD9high subpopulation in the
previous works and in the GCTM-2highCD9highEPCAMhigh cells
in the current RNA-seq study. Expression levels of the gene panel
characteristic of the inner cell mass, preimplantation epiblast and
early post-implantation epiblast were found at appreciable levels
in self-renewing hPSC in all studies. Those genes with highest
expression levels in all three cynomolgus epiblast populations, or
in early and late post-implantation epiblast, were expressed
robustly in all hPSC subpopulations in all studies. The gene panel
specific to late post-implantation epiblast and gastrulating
populations was expressed at somewhat lower levels in all of our
populations relative to pan-epiblast specific genes. Last, genes
characteristic of gastrulation stages 2A and 2B (nomenclature,
ref. 44) were expressed at low levels in the GCTM-2high-
CD9highEPCAMhigh and GCTM-2highCD9high and GCTM-2mid-
CD9mid subpopulations, with levels rising in the GCTM-
2lowCD9low and GCTM-2−CD9− fractions. Thus, these data
support the same conclusion as PCA of the single cell data: hPSC
cell subpopulations enriched for self-renewal capacity show a
pattern of gene expression that is strongly similar to early
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post-implantation epiblast stages in the primate embryo, but
clearly distinguished from inner cell mass or gastrulation stages.
Discussion
We showed previously that the minority ESR subpopulation of
hPSC can be isolated with cell surface markers and identified by
colony formation assay. Colony formation measures both survival
and self-renewal, and dissociation to single cells and flow cyto-
metry compromises survival. We have used several assay strate-
gies to avoid conflation of survival and self-renewal16,17, but the
approach described in this study of isolating aggregates is simple,
and yields defined subpopulations with high initial survival for
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subsequent analysis. Although the initial survival of aggregates of
the hPSC subpopulations was similar, further development of
viable stem cell colonies was observed predominantly in the
fraction bearing the highest level of stem cell markers. Time-lapse
video microscopy revealed that cells in the GCTM-2highCD9high
fraction formed microcolonies that persisted during extended
propagation, whereas microcolonies of cells in the lower fraction
underwent gradual extinction. This is similar to the observations
of Barbaric et al.46, who found that only a subset of SSEA3-
positive hPSC formed microcolonies that persisted and grew.
Their findings and ours suggest that self-renewal might be a
function of the formation of a critical mass of cells expressing
Fig. 5 Analysis of the metabolism of GCTM-2highCD9highEPCAMhigh cells. a Seahorse XF analysis of oxygen consumption rate (OCR) in the GCTM-
2highCD9highEPCAMhigh (HHH) and unsorted (GEN) cell populations. Data represent means ± standard error. Differences in the measurements of basal
respiration and respiration after oligomycin, FCCP, and rotenone/antimycin between the HHH and general cell population were compared in a two-talied
t-test; the p-values was 0.0000031, 0.0025, 0.0032, and 0.005, respectively, for six biological replicates per condition with three measurements each.
b Metabolomic analysis of GEN and HHH cells. Unsupervised hierarchical cluster analysis of metabolite levels determined by LC–MS differing between
the two samples (t-test with Benjamini–Hochberg FDR= 0.05) in replicate samples leads to clear separation of the two populations. The metabolite
abundance values are normalized by scaling to zero mean and unit variance by compound. Cells colored red denote higher abundance, while blue denotes
lower abundance. c Levels of TCA cycle intermediates are elevated in GCTM-2highCD9high cells. Polar metabolites from unfractionated hPSC and GCTM-
2highCD9high cells were analyzed by GC–MS and relative abundance of TCA cycle intermediates after medium normalization shown as box plots. Values
are means ± standard error of three biological replicates. For each boxplot, the bisecting line of each box represents the median. The top and bottom ends
of each box are the 75th and 25th percentiles, respectively. The top and bottom horizontal lines extending out of each box are the minimum and maximum
values, respectively. d HHH and GEN cells were metabolically labeled with 13C glucose for 2 h and 13C-enrichment (expressed as mol%) in select
intermediates measured by GC–MS.
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survival or growth factors at a sufficiently high local level. We
have shown that cells in the GCTM-2highCD9high or GCTM-
2highCD9highEPCAMhigh fractions express the highest levels of
components of the NODAL signaling pathway16,17. Recent results
in zebrafish indicate that cell–cell contacts are key to Nodal sig-
naling47, suggesting the possibility that hPSC might similarly
depend on a positive feedback loop of NODAL signaling and
cell–cell adhesion to drive self-renewal.
In the mouse, under appropriate culture conditions, naive cells
pass through an intermediate state between naive and primed
pluripotency, and in this transient state, are competent to
undergo germline differentiation21. It was previously reported
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that archetypal hPSC can form primordial germ cell-like cells22.
We confirm this finding and show that ESR hPSC have the
capacity for germline differentiation. This distinguishes these cells
from the naive and primed states in the mouse.
Cells in the GCTM-2highCD9highEPCAMhigh fraction displayed
a cell cycle with a very limited G1 fraction relative to other cells in
the population. It has been shown that hPSC pause in G1 when
preparing to embark on differentiation25,26,28. It is possible that
ESR stem cells do not execute such a differentiation checkpoint
and continue in a self-renewing loop, until a pause in the cell cycle
is activated, possibly through an RB-dependent mechanism48.
Cells in the GCTM-2highCD9highEPCAMhigh fraction show
higher mitochondrial membrane potential and increased oxidative
phosphorylation compared with the general population. Compre-
hensive metabolite profiling and 13C-glucose labeling studies
confirmed increased rates of catabolism of pyruvate in the mito-
chondrial TCA cycle. These studies also showed that increased
TCA cycle flux in the GCTM-2highCD9highEPCAMhigh cells is used
to generate key intermediates including citrate and α-ketoglutarate
which are subsequently exported from the mitochondria and used
for synthesis of lipids and amino acids/proteins. Elevated rates of
amino acid synthesis in the GCTM-2highCD9highEPCAMhigh cells
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was also supported by increased flux of glycolytic intermediates
into serine and glycine synthesis. The high rate of de novo
synthesis of cholesterol in hPSC is unusual and further highlights
the importance of TCA cycle in generating precursors (i.e., citrate)
for this pathway. Overall, these data indicate that the GCTM-
2highCD9highEPCAMhigh cells retain a highly active anabolic
metabolism.
DNA methylation levels in mouse naive ES are generally low,
similar to the pattern in the preimplantation epiblast, and rise
in vivo as development progresses toward gastrulation. In the
mouse or primate post-implantation embryo, DNMT3A and
DNMT3B, and TET1 are activated shortly after implantation36.
Levels of methylation in the GCTM-2highCD9highEPCAMhigh and
general population were similar in this study, and considerably
lower than levels reported for mouse epiblast stem cells. In
human hPSC, co-expression of DNA methyltransferases and TET
enzymes could account for the dynamic nature of DNA methy-
lation, exemplified by the dramatic response of these cells to the
presence of ascorbic acid, an activator of TET enzymes, in the cell
culture medium49.
In contrast to DNA methylation levels, chromatin accessibility
varied strikingly in the cell subpopulations that we studied.
Chromatin regions that showed high accessibility in the GCTM-
2highCD9highEPCAMhigh mapped to sites of previously identified
pluripotency transcription factor binding in hPSC, and to sites of
DNAse hypersensitivity that were found to be unique to stem
cells. This pattern changed markedly in the GCTM-2midCD9mid
population. These findings suggest that targets of pluripotency
transcription factors in the GCTM-2highCD9highEPCAMhigh cell
fraction might be involved in the regulation of self-renewal. We
found no evidence for enrichment of binding sites for TFAP2C in
open chromatin in our GCTM-2highCD9highEPCAMhigh cells,
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Fig. 9 String section plot comparison of expression of embryonic stage-specific genes by scRNA-seq in cynomolgus embryo30 with expression in
subpopulations of hPSC. The violin plots in the left hand column show expression from single-cell RNA-seq data in ref. 30, with classification of cells as
described therein; embryonic stages in which particular gene sets (Supplementary Table 4, each row in the figure displays violin plots for one gene set) are
expressed are listed to the left of the plots. The second column shows microarray data from ref. 27 for the same sets of genes in GCTM-2highCD9high (H),
GCTM-2midCD9mid (M), GCTM-2lowCD9low (L), and GCTM-2negCD9neg (N) subpopulations of MEL1 cells grown in the presence of medium containing
Knockout Serum Replacer on mouse embryo fibroblast feeder cell layers (MEF/KSOR), or WA09 cells grown in MEF/KSOR or mTeSR defined medium. The
third column shows microarray data from ref. 16 for the same sets of genes on GCTM-2highCD9high (H), GCTM-2midCD9mid (M), GCTM-2lowCD9low (L),
and GCTM-2negCD9neg (N) subpopulations of ES02 cells grown in serum-containing medium on mouse embryo fibroblast feeder cell layers (MEF/FCS).
The last column shows RNA-seq bulk data on the same sets of genes from the current study for GCTM-2highCD9highEPCAMhigh (HHH) and unsorted (GEN)
cells. Colors of violins correspond to embryonic stages or cell subpopulations identified in labels at left or top of figure (last three columns), respectively.
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thus distinguishing this population from the naive state of hPSC
described earlier50.
The properties of the ESR subpopulation of hPSC discussed
above are consistent with those of the mouse early post-
implantation epiblast. The ability of archetypal hPSC to
undergo differentiation into amnion51–53 or the germline22,54 is
also consistent with a phenotype closer to an earlier post-
implantation state rather than to the EpiSC. We have confirmed
the capacity of archetypal hPSC for germline differentiation, a
capacity which is found in the majority of the population of
archetypal hPSC grown in defined conditions; further study with
refinements to this assay will be required to confirm a higher
capacity for germline differentiation in GCTM-2high-
CD9highEPCAMhigh cells. We previously used embryoid body
assays16 to show that the ESR subpopulation is pluripotent, as did
another study using the teratoma assay19. These findings are not
surprising, since flow cytometry analyses of replated populations
of the ESR subpopulation reported here (Fig. 1a vs. 1c) and in a
more extensive previous work19 indicate that this subpopulation
can eventually regenerate the entire hierarchy of archetypal hPSC.
Here quantitative assessment of directed differentiation into three
germ layer lineages in adherent cultures confirmed that both the
ESR and the remaining population are pluripotent. Together, our
current data and the previous work are consistent with a devel-
opmental equivalence of the ESR with early post-implantation
epiblast, and not naive or primed pluripotent states.
Previous studies have indicated that gene expression in
archetypal hPSC aligns with the primate post-implantation but
not preimplantation epiblast44,45. Our studies on the gene
expression in the subpopulation of hPSC with a high capacity for
self-renewal are consistent with these findings. The post-
implantation epiblast persists longer in the primate than in the
mouse, and it is difficult to resolve changes in epiblast gene
expression during the post-implantation period until gastrulation,
when pluripotency genes turn off and the activation of lineage-
specific programs occurs. Our results here and elsewhere
demonstrate that the cell cycle and metabolic profile, and the lack
of lineage priming in the archetypal hPSC subpopulation showing
a high capacity for self-renewal, are all consistent with early post-
implantation epiblast, but not an mouse EpiSC-like state. Whe-
ther a subpopulation within mouse EpiSC cultures with high self-
renewal capacity exists is unknown.
Recently Nakanishi et al.55 also described a subpopulation of
hPSC with high self-renewal capacity. These cells, which reside at
the periphery of hPSC colonies, were isolated on the basis of cell
surface expression of NCAD, and display priming toward the
primitive endoderm lineage. We previously identified a subset of
cells at the periphery of hPSC colonies which co-isolated with the
self-renewing subpopulation and similarly co-expressed plur-
ipotency and primitive endoderm genes (GATA4/GATA6/
HNF4A/BMP2/FN1)16. We found that these cells were more
abundant in cultures grown in medium supplemented with serum
replacement on a feeder cell layer relative to defined conditions;
they were quite rare in the HSR subpopulation isolated from
cultures grown in defined medium16. We did not observe cells
expressing markers of primitive endoderm in the current study. It
is possible that these lineage primed cells are descendants of the
subpopulation we describe here. Determination of the relation-
ship between the NCAD+ cells and the HSR fraction we have
identified will require further analysis, but it is clear that the
majority of HSR cells in hPSC cultures grown under defined
conditions resemble the early post-implantation epiblast, and not
primitive endoderm. Cornacchia et al.56 recently reported that
hPSC cultured in E8 media display features that are intermediate
between naive and primed hPSC. We have used E8 and mTeSR
interchangeably in these studies and have not noted differences
between the two with respect to the parameters we have studied.
Several features of the E8 cultures described by Cornacchia et al.56
including increased capacity for self-renewal, pluripotency asso-
ciated marker and gene expression, and the metabolome, are
similar to the properties of the ESR population we describe. A
simple interpretation of both sets of data and consistent with
prior observations16,43 is that culture in defined media shifts the
overall population toward the ESR state.
The self-renewing subpopulations of archetypal hPSC that we
have identified here and elsewhere represent a minority of the
culture with distinct properties. The majority of the archetypal
hPSC population shows features closer to mouse EpiSC, as noted
by others. Even under the defined culture conditions used in this
study that enhance self-renewal, transcriptional evidence of
neural lineage priming is evident in the general population. The
development of methods to propagate pure populations of self-
renewing archetypal hPSC populations in a state similar to the
formative stage in mouse might enhance the efficiency of cloning
and differentiation protocols, and reduce the variability in dif-
ferentiation efficiency often observed between hPSC lines from
different genetic backgrounds. Further elucidation of the mole-
cular regulatory pathways that maintain cells in this state will
enhance our understanding of human development and guide
efforts to model embryology in a dish.
Methods
hPSC culture, differentiation, and marker expression. Experimental procedures
for culture and differentiation of human embryonic stem cells, indirect immuno-
fluorescence microscopy and flow cytometry followed minor modifications to
established protocols.
hPSC culture. Human embryonic stem cell stocks (WA09 and FUCCI-G1) were
maintained as described previously57. The FUCCI cells were a gift from Prof Jonathan
S. Draper29. Routine maintenance of hPSC was carried out in serum-supplemented
medium with fibroblast feeder cell support and subculture was performed using
Dispase or collagenase to harvest fragments of colonies dissected manually.
For experiments, cells were transferred to defined feeder-free conditions
(mTeSR conditions) using either mTeSR1 medium or Essential 8™ medium on
Matrigel or recombinant vitronectin and subculture performed with Dispase or
Tryple Express according to the manufacturers’ protocols.
For dissociation to single cells, cultures were treated with 10 μM of
InSolution™Blebbistatin (Merck Millipore cat. no. 203389) for 1 h prior to
dissociation to single cells using TrypLE™ (Life Tech, cat. no. 12605). Cultures were
incubated in media supplement with 10 μM of InSolution™Blebbistatin overnight
after which Blebbistatin was removed.
Routine tests confirmed the absence of mycoplasma contamination and a
diploid karyotype (20/20 cells on G-banding) in the cell lines used.
Fluorescence activated cell sorting for colony formation assays. Cells grown for
24 h in the presence of Y-27632 Rho kinase inhibitor were dissociated using Accutase,
harvested, and examined under the microscope to ensure that most of the cells had
not completely dissociated into single cells. Immunolabeling was carried out by
incubation in a primary antibody cocktail containing TG30 anti-CD9 antibody
(mouse IgG2a) and GCTM-2 (mouse IgM) (neat supernatants, this laboratory) for 20
min at 4 °C, followed by incubation in a secondary antibody cocktail containing goat
anti-mouse IgG2a Alexa Fluor 488 antibody and goat anti-mouse IgM Alexa Fluor
647 antibody (A21131, A21238, both from Thermofisher), diluted in 2% FBS in
DMEM-F12 flow cytometry buffer, again at 4 °C for 20min. The cells were resus-
pended the cells in 1x DAPI in cold mTeSR1 before filtering the suspension through a
35-µm cell strainer to remove any larger aggregates and debris. Commercial anti-
bodies were used at the dilutions recommended by the manufacturer.
All cell sorting was performed on a BD FACSAria III, using the 100-µm nozzle
at 17 psi. A custom cytometer configuration was created that used the 17 psi
pressure as opposed to the typical 20 psi pressure. This was performed to minimize
aggregates from dissociating into single cells as they were deposited into the 96-well
plates. To isolate the GCTM-2highCD9high and GCTM-2midCD9mid fractions of
aggregates and single cells, the gating strategy in Fig. 1a was used (forward and side
scatter were employed to gate out debris and to identify single cells and aggregates;
propidium iodide or AAD-7 was used to identify dead cells). The various fractions
were deposited into 96-well tissue culture plates coated with Matrigel via the
automated cell deposition unit on the Aria III. Subsequent to sorting, tissue culture
plates were centrifuged at 200 × g for 2 min at room temperature. The sheath
solution and media containing mixture was discarded and replaced with 150 µL of
mTeSR1 medium.
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Single cells from each of two FACS populations (GCTM-2highCD9high and
GCTM-2midCD9mid) were plated at a density between 100 and 4000 cells per well
of a 96-well Matrigel-coated plate. Aggregates from each of two FACS populations
were placed between 50 and 2000 aggregates per well of a 96-well Matrigel-coated
plate (Corning, Costar 3603). Cultures were maintained in mTESR1 with medium
changed once after 48 h post-plating. After 72 h, wells were fixed and stained for
colony counting as follows. The culture media was removed from cells and each
well rinsed once with PBS prior to fixing with 100% ethanol for 10 min at room
temperature. Ethanol was removed and wells allowed to air dry for 30 min prior to
staining with haematoxylin for 10 min. Wells were then washed four times with
Milli-Q water. In all, 0.08% aqueous ammonia solution was added into each well
and incubated at room temperature for 2 min. After that, the wells were also
washed three times with Milli-Q water and allowed to dry overnight. For time-
lapse video microscopy, cells were imaged during 1–24 h post-plating in an
environmental chamber (Clear State Solutions TCH 885-9G) to maintain a humid
atmosphere with 5% CO2 in air while phase contrast exposures were recorded every
15 min with a Leica SP8 Confocal microscope.
Differentiation potential of hPSC subpopulations. Differentiation into pri-
mordial germ cell-like cells was carried out essentially as described22. Cultures
grown in defined, feeder-free conditions (mTeSR1 medium, above) were sorted
into GCTM-2highCD9high and GCTM-2midCD9mid fractions and plated onto
fibronectin-coated dishes in Glasgow Minimal Essential Medium supplemented
with Activin A (50 ng/ml), CHIR99021 (3 μM), and Y-27632 Rho kinase inhibitor
(10 μM) for induction of incipient mesoderm-like cells. Two days later, cultures
were harvested and replated as aggregates into Glasgow Minimal Essential Medium
supplemented with LIF (10 ng/ml), BMP4 (200 ng/ml), KITLG (100 ng/ml), and
EGF (50 ng/ml), or without these supplements in low attachment 96-well plates.
Samples were taken at Day 0, 2, 4, and 6 and analyzed by flow cytometry for
expression of cell surface ITGA6 and EPCAM using anti-human and mouse
ITGA6 BV421 (Rat IgG2a, Biolegend 313624) and mouse anti-human CD236-
PerCP (Mouse IgG2b, Biolegend 324213). On Day 4, some aggregates were fixed
with 4% paraformaldehyde in PBSA for 30 min, permeabilized in 0.2% TritonX100
and 10% bovine serum albumin in PBSA for 30 min, stained overnight with rabbit
antisera against PRDM1 (rabbit monoclonal IgG clone 9115 from Cell Signaling
Technology) or NANOS3 (rabbit antisera, Abcamab70001), then incubated 1 h
with goat anti-rabbit IgG Alexa488 conjugate, and counterstained with DAPI (Life
Tech, Cat. #D1306), prior to examination under indirect immunofluorescence
microscopy. Commercial antibodies were used at the concentrations recommended
by the manufacturer.
To examine the potential for differentiation into somatic lineages in directed
differentiation assays, we used the StemCell Technologies StemDiff Trilineage
Differentiation Kit. WA09 or WA01 cells were separated by flow cytometry and
seeded onto Matrigel-coated 8-well chamber slides, then incubated in three
differentiation media for 5 days following the manufacturer’s instructions. Then
the cultures were fixed in 4% paraformaldehyde in PBSA for 15 min, incubated
with primary antibodies (rabbit anti-PAX6 polyclonal IgG Biolegend Poly19013;
goat anti-T polyclonal IgG R&D AF2085; goat anti-SOX17polyclonal IgG R&D
AF1924) for 3 h, then in secondary antibodies (donkey anti-rabbit IgG Alexa Fluor
Plus 488 A21206; donkey anti-goat IgG Alexa Fluor Plus 488 A11070, both from
Thermofisher) for 1 h followed by counterstaining with DAPI and examination
under indirect immunofluorescence. Sufficient cells from each group were counted
to attain a 95% confidence interval of <0.05% for the proportion of positive cells.
Commercial antibodies were used at the concentrations recommended by the
manufacturer.
Analytical and preparative flow cytometry. All single-cell analytical sorting was
performed on a BD FACSAria III, using the 100 µm nozzle at 20 psi. Single cells
were stained and quantified for the following cell surface markers, GCTM-2 and
TG30 or GCTM-2, TG30, and EPCAM. Cells were stained in solution using a
mixture of GCTM-2 (mouse IgM, neat hybridoma supernatant) and TG30 (anti-
CD9, mouse IgG2a, neat hybridoma supernatant) (double stain) and anti-EPCAM-
BV421 (BD Cat. #563180) (triple stain). Primary antibodies against GCTM-2 and
TG30 were detected using goat anti-mouse IgM-AF647 (A21238) and goat anti-
mouse IgG2a-AF488 (A21131), respectively (Life Tech, Carlsbad, CA). Rat anti-
mouse IgG2a Secondary Antibody, PE/Cy7 (RMG2a-62, 407107 Biolegend), was
used to detect TG30 in experiments that used FUCCI cell lines, mitochondrial
membrane potential dyes, or for the Click-iT® EdU Alexa Fluor® 488 Flow
Cytometry Assay (Thermo Fisher, Cat. #10425). Commercial antibodies were used
at the concentrations recommended by the manufacturer.
Control samples included unlabeled cells, cells labeled with secondary antibody
only and single fluorochrome labeled cells. Cells were sorted using a FACSAria (BD
Biosciences) with a 100 μM nozzle and low-pressure conditions. Cells were first
gated based on forward and side scatter properties then were analyzed for levels of
GCTM-2, TG30, and EPCAM labeling. Double stained cells (GCTM-2 and TG30)
were sorted into several populations: GCTM-2lowCD9low, GCTM-2highCD9high, or
GCTM-2highCD9highEPCAMhigh. The low population consists of cells with low
(bottom 25%) expression of GCTM-2 and TG30, the GCTM-2highCD9high subset
consists of the top 25% of cells expressing GCTM-2 and TG30, whereas the
GCTM-2highCD9highEPCAMhigh subset is a fraction of the GCTM-2highCD9high
population with the highest expression of EPCAM, representing ~10% of GCTM-
2highCD9high fraction. Sorted single cells were processed for gene expression
analysis as described below. In some experiments GCTM-2highCD9highEPCAMhigh
cells were compared with an unsorted (general) population.
For TMRM or JC-1 analysis, rat anti-mouse IgG2a Secondary Antibody, PE/
Cy7 (Biolegend 407107, RMG2a-62) was used to detect TG30. 1 × 106 single cells
that were stained with antibodies were resuspended in 1 mL of
mTeSR1 supplemented with 250 nM TMRM (Thermo Fisher, Cat. #T668) or 0.3
μg/mL JC-1 (Thermo Fisher, Cat. #T3168) and incubated in the incubator for 30
min. The media was subsequently removed and the cells were washed three times
with mTeSR1 before analysis on the flow cytometer.
For Edu incorporation, rat anti-mouse IgG2a Secondary Antibody, PE/Cy7
(Biolegend, 407107, RMG2a-62) was used to detect TG30. Stained single cells were
subsequently labeled with Click-iT® EdU Alexa Fluor® 488 Flow Cytometry Assay
kit (Thermo Fisher, Cat. #10425) according to manufacturer’s method.
All FACs plots were created using FCS express (De Novo Software) and the
coefficient of variation was also calculated using FCS express or using the FloJo
software package.
Immunofluorescence microscopy. For staining of cells in colony formation
assays, H9 cells that were cultured in 96-well matrigel-coated plates were washed
twice with PBS prior to fixation with 2% paraformaldehyde (PFA) for 30 min at
room temperature. Cells were permeabilized with 0.3% Triton X-100 in PBS and
blocked with 1% IgG-free BSA, incubated in antibody GCTM-2 overnight at 4 °C,
followed by goat anti-mouse IgM Alexa Fluor 488 for 30 min. Samples were then
washed with PBS and counterstained with DAPI (Life Tech, Cat. #D1306).
For co-staining of live cells, anti-CD9 primary antibody was preincubated with
with goat anti-mouse IgG2a-AF488 (A21131). WA09 hPSC were incubated with
mTeSR1 containing 250 nM TMRM (Thermo Fisher, Cat. #T668) and AF488
bound TG30 for 30 min at 37 °C and the cells were then washed three times with
warmed mTeSR1 before they were visualized under indirect fluorescence
microscopy.
Metabolomics studies. The GCTM-2highCD9highEPCAMhigh subpopulation or
unsorted cells were plated in 6-well format and allowed to expand for 24 h. Spent
media was aspirated, and cell cultures were washed once in Milli-Q water to
remove extraneous media, then sufficient liquid nitrogen was added to cover the
base of the culture surface and enable metabolic arrest. Next, cells were incubated
with 600 μl (per 10 cm2 surface area) of ice cold 9:1 MeOH:CHCl3 containing 0.83
µM 13C6-sorbitol and 8.3 µM 13C5,15N-valine for 10 min on ice. The cell lysate was
scraped and then transferred to a clean tube, incubated on ice for another 5 min,
and centrifuged at 16,100 × g for 5 min at 4 °C following which the supernatant was
collected for mass spectrometric analysis.
For stable isotope labeling studies, cells were prepared as described above, but
the culture media was supplemented with U-13C6-glucose for 24 h prior to cell
harvest.
LC–MS intracellular metabolite profiling analysis. Metabolite analysis was
performed by LC–MS, using hydrophilic interaction (HILIC) LC and high reso-
lution QTOF mass spectrometry. Sample extracts (10 μL) were injected onto an
Agilent 1290 LC fitted with a ZIC-pHILIC column (5 μm, 2.1 × 150 mm; Merck),
and 20 mM ammonium carbonate (A) and acetonitrile (B) as the mobile phases. A
14 min gradient starting from 90% B to 40% B over 12 min, held for 2 min followed
by washing at 5% B for 3 min and re-equilibration at 90% B, was used. Mass
spectrometry utilized an Agilent 6545 QTOF with heated electrospray source
operating in negative ionization mode and scan range m/z 50–1700. Conditioning
was performed before each batch using 2–3 blanks and 5 mixtures of authentic
standards (234 metabolites), which were analyzed in data-dependent MS/MS mode
to facilitate downstream metabolite identification where necessary. PBQC samples
were analyzed periodically throughout the analysis.
GC–MS intracellular metabolite profiling analysis. Five hundred microliters of
the cell extract was evaporated to complete dryness under vacuum (Christ RVC 2-
33). Polar metabolites were derivatised online using a Gerstel MPS2 XL auto-
sampler robot (Gerstel, Germany). Samples were first methoxyaminated by the
addition of 20 µL methoxyamine (30 mg/mL in pyridine, 2 h, 37 °C, 750 rpm),
followed by trimethylsilylation with 20 µL BSTFA+ 1% TMCS (1 h, 37 °C, 750
rpm). Metabolite profiles were acquired on an Agilent 7890A Gas Chromatograph
coupled to a 5975C Mass Selective Detector, where 1 µL of derivatised sample was
injected into a split/splitless inlet set at 250 °C. Chromatographic separation was
achieved using an Agilent VF-5 ms capillary column (30 m × 0.25 mm × 0.25 µm+
10 m duraguard). Oven conditions were set at 35 °C starting temperature, held for
2 min, then ramped at 25 °C/min to 325 °C and held for 5 min. Helium was used as
the carrier gas at a flow rate of 1 mL/min. Compounds were fragmented by electron
impact (EI) ionization and detected across a m/z range of 50–600 amu, with a scan
speed of 9.2 scans/s. Chromatograms were processed using PyMS58 to align
metabolites and quantify a representative target ion, and subsequently generate a
data matrix. Metabolites were annotated using the in-house Metabolomics Aus-
tralia (MA_25C) metabolite library and NIST11 database.
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GC–MS intracellular stable isotope incorporation analysis. Stable isotope
labeled samples were prepared for GC–MS and analyzed as described above. 13C-
targeted metabolomics was performed as previously described59. GC–MS was carried
out using an Agilent 7890 GC system, VF-5 capillary column with 10m inert ezi-
guard (J&W Scientific, 30m, 250 μm inner diameter, 0.25 μm film thickness) and an
Agilent 5975 MSD (Agilent Technologies, Santa Clara, USA) in electron ionization
(EI) mode. We used mass isotopomer peak shift analysis to measure 13C-glucose
derived carbon labeling in key metabolites of the glycolytic and TCA cycle. Elution
times and the fragmentation can be found on the NIST database.
Seahorse flux analysis. The oxygen consumption rate and extracellular acid-
ification rate were determined using an extracellular flux analyzer (Seahorse XFe96
Analyzer, Agilent). GCTM-2highCD9highEPCAMhigh cells and the unsorted
population were seeded into CellTak Cell and Tissue Adhesive (Corning)-coated
wells of a Seahorse XF96 Cell Culture Microplate (n > 6) at 105 cells per well in 180
μl Seahorse XF Assay Medium (supplemented with 10 mM glucose, 2 mM gluta-
mine and 1 mM sodium pyruvate). The mitochondrial electron transport chain was
challenged using the Seahorse XF Mito Stress Test Kit (Agilent). A total of 12
measurement cycles were carried out, each cycle consisting of 3 min mixing and 3
min measurement of the oxygen consumption rate and extracellular acidification
rate. The first three cycles determined the basal rate and 3 × 3 additional cycles
were measured after addition of oligomycin (2 μM final), carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP, 2 μM final) and rotenone/antimycin A
(0.5 μM final each). The data were exported and analyzed using Excel (Microsoft)
and Wave Software (Agilent).
Reduced representational bisulfite sequencing. FACS sorted cells were snap
frozen in buffer RLT plus (Qiagen) before DNA extraction using the AllPrep DNA/
RNA Mini Kit (Qiagen) as per the manufacturer’s instructions. DNA was treated
with RNase A then purified through the DNA Clean and Concentrator column
(Zymo). RRBS libraries were made from 100 ng of purified DNA using the Ovation
RRBS Methyl-Seq System (NuGEN), according to the manufacturers recommen-
dations, which includes the Qiagen Epitect kit for bisulfite conversion. Sequencing
was performed on a NextSeq 500 with a 75 bp single-end sequencing protocol60.
Sequence quality control was performed using FastQC61. Trimming of adapters
and low-quality base calls was performed with trim_galore62. Trimmed reads were
filtered for true RRBS reads (which contain an MspI cut site at the 5ʹ) using
trimRRBSdiversityAdaptCustomers.py (NuGEN). Reads were aligned to a bisulfite
converted human genome (hg38), using Bismark63 Methylation calls were made
with bismark_methylation_extractor63. Analysis of methylation over CpG islands
was performed using Seqmonk64 where only CGIs with 10 or more informative
CpG sites were considered. FastQC, trim_galore, and Seqmonk are all available
from www.bioninformatics.babraham.ac.uk.
Chromatin accessibility. DNA accessibility was measured using the FAST-ATAC
protocol65 with 50,000 sorted cells for each of three biological replicates of both
GCTM-2highCD9highEPCAMhigh and GCTM-2midCD9mid populations. Sorted cells
were pelleted by centrifugation for 5 min at 4 °C, supernatant was removed, and the
cell pellet was washed one time with PBS pH 7.2. Cells were resuspended in 50 µl of
transposase mixture consisting of 25 µl of 2x TD buffer (Illumina), 2.5 µl of TDE1
enzyme (Illumina), 0.5 µl of 1% digitonin (G9441, Promega), and 22 µl of nuclease-
free water. Transposase reactions were incubated at 37 °C for 30 min with constant
shaking in an Eppendorf ThermoMixer. Following transposition, DNA was pur-
ified using the Zymo DNA Clean and Concentrator-5 Kit (#D4014) following
manufactures protocol and eluted in 20 µl of 10 mM Tris-HCL, pH 8. Transposase
samples were barcoded using duel indexes during library amplification using
NEBNext Ultra II Q5 Master Mix (#M0544L), 25 µM of each primer, and 20 µl of
transposed DNA. Libraries were amplified for a total of nine cycles (98 °C for 10 s,
63 °C or 30 s, 72 °C for 1 min), followed by purification using AMPure beads
(Beckman Coulter #A63881). ATAC-seq libraries were visualized on Bioanalyzer
for typical nucleosome banding followed by sequencing on the Illumina Next-Seq
platform. Libraries were trimmed using trimmomatic66 and aligned to Ensemble
(build hg19) using bwa67 with default settings. Duplicates reads were removed
using Picard tools MarkDuplicates, and each aligned read was shifted toward the
Tn5 cut site as described37. As reported, we found that FAST-ATAC resulted in
low percentages of reads mapping to mitochondria (Supplementary Fig. 4a).
Regions of open chromatin were determined by combining alignment files across
replicates and using MACS v.1.4.368. Open chromatin regions were merged between
both high and low samples to form a universal set of peaks (peakome), and regions
from ENCODE blacklist removed. Reads were quantified for each interval in the
peakome using bedtools69 and normalized using TMM method70. We found that
each sample had a high fraction of reads in the peakome, showed strong enrichment
for open chromatin at transcription start sites, and characteristic distribution of
fragments showing nucleosome free regions and mono- and di-nucleosome patterns,
indicating high-quality ATAC libraries (Supplementary Fig. 4b–d). Data exploration
using principle component analysis (PCA) found that the first PCA, explaining 43%
of the variance, separated high and low populations, while the second PCA repre-
sented potential batch effects (Supplementary Fig. 4e, f). Based on these observations,
a general linearized model in edgeR70 was used to identify differences in DNA
accessibility between populations including batch as a covariate. Peak set annotations
and enrichments were calculated using LOLA39 by comparing peaks more accessible
in either high or low populations (FDR < 0.01, Supplementary Table 1) with the
universal set of DNAse hypersensitivity sites as the universe against the LOLA core
(Supplementary Data 2). Statistical analysis, data exploration, and visualization was
performed using R (http://www.R-project.org).
Single-cell RNA sequencing. Single cells were flow sorted into a chilled 384-well
PCR plate containing 1.2 μl of primer/lysis mix [20 nM indexed polydT primer,
1:6,000,000 dilution of ERCC RNA spike-in mix (Ambion, 4456740), 1 mM
dNTPs, 1.2 units SUPERaseIN Rnase Inhibitor (Thermo Fisher, AM2696), DEPC
water (Thermo Fisher, AM9920)] using a BD FACSAria III flow cytometer (BD
Biosciences, San Jose, CA, USA) and the protocol described above. Sorted plates
were sealed, centrifuged for 1 min at 3000 rpm and immediately frozen upside
down at −80 °C until further processing using an adapted CelSeq2 protocol71.
Sorted plates were thawed on ice and briefly centrifuged. To lyse the cells and
anneal the mRNA capture primer the plate was incubated at 65 °C for 5 min and
immediately chilled on ice for at least 2 min before adding 0.8 μl reverse
transcription reaction mix [in 2 μl RT reaction: 1x Fist Strand buffer (Invitrogen,
18064-014), 20 mM DTT (Invitrogen, 18064-014), 4 units RNaseOUT (Invitrogen,
10777-019), 10 units SuperScript II (Invitrogen, 18064-014)]. The plate was
incubated at 42 °C for 1 h, 70 °C for 10 min and chilled to 4 °C to generate first
strand cDNA. For second strand cDNA synthesis 6 μl of second strand reaction
mix were added [1x NEBNext Second Strand Synthesis buffer (NEB #E6111S),
NEBNext Second Strand Synthesis Enzyme Mix: 2.4 units DNA Polymerase I (E.
coli), 2 units RNase H, 10 units E. coli DNA Ligase (NEB #E6111S), DEPC water
(Thermo Fisher, AM9920)]. The plate was incubated at 16 °C for 2 h to generate
double stranded cDNA.
All samples were pooled and cleaned using a 1.2X NucleoMag NGS Clean-up
and Size select magnetic beads (Macherey-Nagel, 7449970.5) according to
manufactures instruction. To reduce the amount of beads for each 100 μl pooled
sample, 20 μl beads and 100 μl bead binding buffer (20% PEG8000, 2.5 M NaCl, pH
5.5) was added. The cDNA was eluted in 6.4 μl DEPC water and kept with beads
for the following IVT reaction were 9.6 μl of IVT reaction mix [1.6 μl of each of the
following: A, G, C, U, 10X T7 buffer, T7 enzyme (MEGAscript T7 transcription kit
(Ambion, AM1334))] was added and incubated at 37 °C for 13 h and then chilled
and kept at 4 °C. To remove the leftover primers, 6 μl ExoSAP-IT For PCR Product
Clean-Up (Affymetrix, 78200) was added and the sample was incubated at 37 °C
for 15 min and then chilled and kept at 4 °C.
Chemical heat fragmentation was performed by adding 5.5 μl of 10X
Fragmentation buffer (RNA fragmentation reagents, AM8740) to the sample and
incubation in pre-heated thermal cycler at 94 °C for 2.5 min followed by
immediately chill on ice and addition of 2.75 μl of Fragmentation Stop buffer (RNA
fragmentation reagents, AM8740). The fragmented amplified RNA was purified
using 1.8X RNAClean XP beads (Beckman Coulter, A63987) according to
manufactures instruction and eluted in 6 µl DEPC water of which 5 μl (no beads)
were transferred to a fresh tube for library preparation.
The fragmented RNA was transcribed into cDNA using 5ʹ-tagged random
hexamer primers (GCCTTGGCACCCGAGAATTCCANNNNNN) introducing a
partial Illumina adapter as also described in ref. 71. To remove RNA secondary
structure and anneal the mRNA capture primer 1 μl of tagged random hexamer
(100 µM) and 0.5 μl of 10 mM dNTPs (dNTP solution set NEB, N0446S) were
added to the sample and incubated at 65 °C for 5 min and immediately chilled on
ice for at least 2 min before adding 4 μl reverse transcription reaction mix [in 10 μl
RT reaction: 1x First Strand buffer (Invitrogen, 18064-014), 20 mM DTT
(Invitrogen, 18064-014), 4 units RNaseOUT (Invitrogen, 10777-019), 10 units
SuperScript II (Invitrogen, 18064-014)].
The PCR primers introduce the full-length adaptor sequence required for
Illumina sequencing (for details see Illumina small RNA PCR primers). PCR was
performed in 12.5 μl using half of the ranhexRT sample as a template [1X KAPA
HiFi HotStart ReadyMix (KapaBiosystems KK2602), 400 nM each primer].
The final PCR amplified Library was submitted to two consecutive 1x
NucleoMag NGS Clean-up and Size select magnetic beads (Macherey-Nagel,
7449970.5) according to manufactures instruction. The final library was eluted in
20 μl of 10 mM Tris-HCl solution (Sigma-Aldrich, T2319-1L).
RNA-seq data analysis. CelSeq2 scRNA-sequencing reads were mapped to the
GRCh38 human genome using the Subread aligner72 and assigned to genes using
scPipe73 with ENSEMBL v86 annotation. Gene counts were exported as a matrix by
scPipe with UMI-aware counting and imported into R. Cells were removed from
further analysis if they fewer than 12,500 total counts, or >60,000 total counts, or
4500 total genes detected. Genes were filtered out if they failed to achieve 1 count in
at least 10% of a particular cell condition group. Heatmaps were generated on
normalized expression values using heatmap2 from the gplots package with row
normalization. Dimensionality reduction was performed on normalized log2-cpm
expression values with size factors from computeSumFactors in scran74. Single-cell
RNA-seq data are available through the Gene Expression Omnibus under accession
number #:GSE119323.
The non-human primate data were generated on the SC3-seq platform75 and
are publicly available under GEO accession number GSE74767. In order to
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compare between human and macaque expression levels, we defined a set of high
confidence orthologous metaexons between the two species as in ref. 76. Briefly, we
used BLAT77 to compare every annotated human exon in ENSEMBL release 86
(737,982 unique exons across 63,305 genes) against the human (hg38) and Macaca
fascicularis (macFas5) genomes, retaining those that matched the macaque genome
with at least 92% sequence identity and mapped back to their annotated location in
humans. We then excluded all exons that had a second match with >90% sequence
similarity in either genome, to control for interspecies differences in mappability.
Overlapping exons from the same gene (associated with different isoforms) were
collapsed into a single “metaexon”.
We discarded overlapping exons associated with more than one ENSEMBL
gene ID, exons associated with any gene annotated to two or more chromosomes in
either species, and exons where the difference in intron size between the two
species is ≥10,000 bp, suggestive of poor genome assembly or annotation. After
applying these quality control criteria, we ultimately retained 198,172 unique
metaexons in humans and macaques across 34,142 annotated ENSEMBL human
genes. The final table, as well as code and additional documentation for metaexon
identification is available at http://www.bitbucket.org/ee_reh_neh/orthoexon
We processed all 2526 files from ref. 44 (from 390 cells) with sickle [https://github.
com/najoshi/sickle] to remove bad reads and trim low-quality bases from the 3ʹ end.
We then mapped all reads to macFas5 using Rsubread 1.20.6 and R 3.2.2, allowing up
to 2 mismatches and 2 indels per 50 bp read, which is proportional to our setting of 5
mismatches or indels for a 100 bp read. Mapped reads were assigned to the
orthologous metaexon list using featureCounts at both the single metaexon and
whole-gene level, and summed within individuals in R 3.2.2.
Human scRNA-seq data processing. Sequence analysis was performed on the
Illumina Next-Seq 500 platform.
Quality control of raw data was assessed using FASTQC and visualized using
MultiQC. The scPipe package v1.0 for R was used to count genes based on UMI
profile. Gene expression was normalized using scaterv1.6.1 and scran
v1.6.6packages for R. FASTQ files were aligned to hg38 using the Subread package
v1.26.1 for R statistical software, aligned reads were re-annotated to exons using
ENSEMBL v86 transcriptome to define the exon/intron mapping rate. Cells with
<4500 expressed genes or more than 60,000 counts were discarded, resulting in 300
of 370 non-control cells retained for downstream analysis.
Data from both species reflected Log2(CPM+ 1) aligned to HG38v86. Data from
both species were mapped to a set of highly orthologous metaexons. Supplementary
Fig. 8 illustrates the distribution of gene expression in each dataset before and after
gene-based filtering. A gene was retained in a given dataset based on expression
above a cut off of 1 (non-human primate) or 5 (human) Log2(CPM+ 1) in at least
10% of cells assigned to a given phenotype. These cutoffs were selected based on the
distribution of gene expression in each dataset. Downstream analysis was limited to
the 7308 genes commonly expressed in each dataset.
To rescale and combine the datasets, each gene was assigned a rank in a given
cell based on its abundance. Ties in the data were assigned the same rank and the
minimum value was used. Supplementary Fig. 9 illustrates the distributions of z-
scores of ranked gene expression for every cell in each dataset. PCA was performed
on the merged data using prcomp function in the stats base package for R statistical
software version 3.3.2. Downstream analysis of the principal components was
performed using the mixOmics package version 6.3.1 for R version 3.3.2.Panther.
db was used to perform Fischer’s exact test for over-representation of ontological
terms in gene sets of interest.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNA-seq, scRNA-seq, and ATAC-seq data are available at Gene Expression Omnibus
under accession Superseries GSE119326 (RNA-seq, GSE119324, scRNA-seq GSE119323,
ATAC-seq GSE147338).
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